Bacterial Infections
258
22
26
174
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
37 trials with published results (14%)
Research Maturity
174 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.7%
12 terminated out of 258 trials
93.5%
+7.0% vs benchmark
19%
49 trials in Phase 3/4
21%
37 of 174 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 174 completed trials
Clinical Trials (258)
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
Microbiology Operations & Time Optimization in Sepsis
Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam vs. Meropenem Using Serum Creatinine and Cystatin-C
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
TDM-optimized Teicoplanin Dosing Versus Standard of Care
Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
Large Algorithm Setting and Validation Study
First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients
Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY)
Personalized Antibiotic Therapy - Point-of-Care Determination of Blood Levels of Beta-Lactam Antibiotics Using Coated-Blade-Spray Ion Mobility Spectrometry
Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
Emergency PWAS in Respiratory Infectious Disease
Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis